Objective: To investigate the doses of antivenom administered to adult patients with severe brown snake envenoming. Design and setting: Review of charts from Western Australian adult teaching hospitals, December 1991 to December 2001. Patients: 35 patients with severe brown snake envenoming, defined prospectively as afibrinogenaemia (< 0.3g/L) after a bite by a brown snake (genus Pseudonaja). Main outcome measure: The dose of antivenom required to neutralise venom, defined prospectively as the dose of antivenom given before the return of detectable fibrinogen levels. Results: Of 88 patients with brown snake envenoming admitted over the 10 years, at least 35 had severe envenoming. Afibrinogenaemia persisted for 10 hours (range, ...
We aimed to describe the characteristics, clinical course, management and outcome of patients presen...
Objective: To describe the clinical features and laboratory findings in patients with definite red-b...
We aimed to describe the characteristics, clinical course, management and outcome of patients presen...
Objective: To investigate the doses of antivenom administered to adult patients with severe brown sn...
BACKGROUND: Snakebite is a global health issue and treatment with antivenom continues to be problema...
Background: Snakebite is a global health issue and treatment with antivenom continues to be problema...
Background: Snakebite is a global health issue and treatment with antivenom continues to be problema...
spp.) envenoming, and determine the dose of antivenom required. venom. From January 2004 to January...
spp.) envenoming, and determine the dose of antivenom required. venom. From January 2004 to January...
Context: Mulga snakes (Pseudechis australis) are venomous snakes with a wide distribution in Austral...
BACKGROUND: Snakebite is a global health issue and treatment with antivenom continues to be problema...
Objective: To describe the epidemiology, clinical features, treatment and outcomes of patients with ...
Background: Currently, there is inadequate evidence on which to base clinical management of neurotox...
Currently, there is inadequate evidence on which to base clinical management of neurotoxic snakebite...
Currently, there is inadequate evidence on which to base clinical management of neurotoxic snakebite...
We aimed to describe the characteristics, clinical course, management and outcome of patients presen...
Objective: To describe the clinical features and laboratory findings in patients with definite red-b...
We aimed to describe the characteristics, clinical course, management and outcome of patients presen...
Objective: To investigate the doses of antivenom administered to adult patients with severe brown sn...
BACKGROUND: Snakebite is a global health issue and treatment with antivenom continues to be problema...
Background: Snakebite is a global health issue and treatment with antivenom continues to be problema...
Background: Snakebite is a global health issue and treatment with antivenom continues to be problema...
spp.) envenoming, and determine the dose of antivenom required. venom. From January 2004 to January...
spp.) envenoming, and determine the dose of antivenom required. venom. From January 2004 to January...
Context: Mulga snakes (Pseudechis australis) are venomous snakes with a wide distribution in Austral...
BACKGROUND: Snakebite is a global health issue and treatment with antivenom continues to be problema...
Objective: To describe the epidemiology, clinical features, treatment and outcomes of patients with ...
Background: Currently, there is inadequate evidence on which to base clinical management of neurotox...
Currently, there is inadequate evidence on which to base clinical management of neurotoxic snakebite...
Currently, there is inadequate evidence on which to base clinical management of neurotoxic snakebite...
We aimed to describe the characteristics, clinical course, management and outcome of patients presen...
Objective: To describe the clinical features and laboratory findings in patients with definite red-b...
We aimed to describe the characteristics, clinical course, management and outcome of patients presen...